Delphine Vimont
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Prospective head-to-head comparison of [68Ga]Ga-RM2 PET/CT and [68Ga]Ga-PSMA-617 PET/CT in newly diagnosed patients with intermediate-risk localized prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 22, 2025
N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake.
Journal: Journal of medicinal chemistry
Published: March 20, 2025
Rational design of NT-PSMA heterobivalent probes for prostate cancer theranostics.
Journal: RSC medicinal chemistry
Published: July 02, 2024
Development of Radiopharmaceuticals for NPY Receptor-5 (Y5) Nuclear Imaging in Tumors by Synthesis of Specific Agonists and Investigation of Their Binding Mode.
Journal: Bioconjugate chemistry
Published: August 09, 2023
Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R.
Journal: Cancers
Published: February 17, 2023
Comparison of 68Ga-PSMA-617 PET/CT and 68Ga-RM2 PET/CT in Patients with Localized Prostate Cancer Who Are Candidates for Radical Prostatectomy: A Prospective, Single-Arm, Single-Center, Phase II Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 27, 2022
Erratum to: Striatal and cerebellar vesicular acetylcholine transporter expression is disrupted in human DYT1 dystonia.
Journal: Brain : a journal of neurology
Published: April 23, 2021
Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS1-Positive Tumors Imaging.
Journal: Bioconjugate chemistry
Published: September 05, 2020
Striatal and cerebellar vesicular acetylcholine transporter expression is disrupted in human DYT1 dystonia.
Journal: Brain : a journal of neurology
Published: July 07, 2020
Last Updated: 09/26/2026